•   A unique collection of 113 MAPK signaling inhibitors for high throughput screening (HTS) and high content screening (HCS).

•   Targets such as ERK, JNK, MEK, p38 MAPK, Raf, RSK, etc.

•   A useful tool for MAPK-related drug discovery and disease research.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   More detailed compound information with structure, IC₅₀, and brief introduction.

•   NMR and HPLC validated to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Formulation:

A collection of 113 MAPK/ERK signaling related compounds supplied as pre-dissolved DMSO solutions or Solid

Container:

96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode

Storage:

-80°C

Shipping:

Blue ice

Plate layout: HY-L010-1

Plate layout: HY-L010-2